Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A community-deployable SARS-CoV-2 screening test using raw saliva with 45 minutes sample-to-results turnaround

View ORCID ProfileNicholas R. Meyerson, Qing Yang, Stephen K. Clark, Camille L. Paige, Will T. Fattor, Alison R. Gilchrist, View ORCID ProfileArturo Barbachano-Guerrero, View ORCID ProfileSara L. Sawyer
doi: https://doi.org/10.1101/2020.07.16.20150250
Nicholas R. Meyerson
BioFrontiers Institute, Dept. of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80302, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas R. Meyerson
Qing Yang
BioFrontiers Institute, Dept. of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80302, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen K. Clark
BioFrontiers Institute, Dept. of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80302, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camille L. Paige
BioFrontiers Institute, Dept. of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80302, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Will T. Fattor
BioFrontiers Institute, Dept. of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80302, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison R. Gilchrist
BioFrontiers Institute, Dept. of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80302, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arturo Barbachano-Guerrero
BioFrontiers Institute, Dept. of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80302, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arturo Barbachano-Guerrero
Sara L. Sawyer
BioFrontiers Institute, Dept. of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80302, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sara L. Sawyer
  • For correspondence: ssawyer@colorado.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Up to 70% of SARS-CoV-2 infections in working- and school-age people are asymptomatic (Poletti et al., 2020), creating anxiety over reopening workplaces and schools around the world. In the absence of effective treatments or a vaccine, peace of mind will come only with community-based SARS-CoV-2 screening, where many people are tested on a regular basis. However, recent models show that short sample-to-answer turnaround time will be a critical property of effective screening strategies (Larremore et al., 2020). Here, we describe an RT-LAMP test for SARS-CoV-2 in raw saliva that takes about 45 minutes from sample to answer and requires only simple equipment (pipettes and a heating source). The assay has a limit of detection of 100 virions per microliter, and targets two separate regions of the SARS-CoV-2 genome. By combining rapid sample-to-answer turnaround time with the use of saliva, our RT-LAMP assay provides a low-complexity, portable, and robust system for real-time community screening.

Competing Interest Statement

Some of the authors of this study (NRM, QY, CLP, SLS) are founders of Darwin Biosciences, who licenses the RT-LAMP assay described herein.

Funding Statement

We thank the Burroughs Wellcome Fund (PATH award to SLS; PDEP award to NRM) and NIH (DP1-DA-046108 and R01-AI-137011 to SLS) for funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The University of Colorado Boulder IRB determined that this study is not research involving human subjects as defined by DHHS and/or FDA regulations and therefore does not require IRB approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is included in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted July 17, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A community-deployable SARS-CoV-2 screening test using raw saliva with 45 minutes sample-to-results turnaround
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A community-deployable SARS-CoV-2 screening test using raw saliva with 45 minutes sample-to-results turnaround
Nicholas R. Meyerson, Qing Yang, Stephen K. Clark, Camille L. Paige, Will T. Fattor, Alison R. Gilchrist, Arturo Barbachano-Guerrero, Sara L. Sawyer
medRxiv 2020.07.16.20150250; doi: https://doi.org/10.1101/2020.07.16.20150250
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A community-deployable SARS-CoV-2 screening test using raw saliva with 45 minutes sample-to-results turnaround
Nicholas R. Meyerson, Qing Yang, Stephen K. Clark, Camille L. Paige, Will T. Fattor, Alison R. Gilchrist, Arturo Barbachano-Guerrero, Sara L. Sawyer
medRxiv 2020.07.16.20150250; doi: https://doi.org/10.1101/2020.07.16.20150250

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9782)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2318)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11656)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (239)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2148)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4673)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)